Susan A. Fotheringham

Oxford Science Park
Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

A hyperimmune ovine antibody-based therapeutic candidate against Crimean-Congo haemorrhagic fever virus targeted to the Gn and Gc glycoproteins: high antibody levels with neutralization activity but lack of protective efficacy in a mouse model.

A hyperimmune ovine antibody-based therapeutic candidate against Crimean-Congo haemorrhagic fever virus targeted to the Gn and Gc glycoproteins: high antibody levels with neutralization activity but lack of protective efficacy in a mouse model.

Journal: Antibody therapeutics
Published: December 18, 2025

Protective immunity in hamsters from an oral Nipah vaccine correlates with pseudovirus neutralising antibody titre.

Protective immunity in hamsters from an oral Nipah vaccine correlates with pseudovirus neutralising antibody titre.

Journal: Scientific reports
Published: October 20, 2025

Corrigendum: Susceptibility and transmission of mpox virus infection in brown rats (Rattus norvegicus).

Corrigendum: Susceptibility and transmission of mpox virus infection in brown rats (Rattus norvegicus).

Journal: The Journal of general virology
Published: October 10, 2025

Susceptibility and transmission of mpox virus infection in brown rats (Rattus norvegicus).

Susceptibility and transmission of mpox virus infection in brown rats (Rattus norvegicus).

Journal: The Journal of general virology
Published: July 01, 2025

An adenoviral-vectored vaccine protects mice against aerosol challenge with Yersinia pestis.

An adenoviral-vectored vaccine protects mice against aerosol challenge with Yersinia pestis.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 25, 2025

An Adenoviral Vectored Vaccine Protects Mice Against Aerosol Challenge with Yersinia pestis.

An Adenoviral Vectored Vaccine Protects Mice Against Aerosol Challenge with Yersinia pestis.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 25, 2025

Genomic changes of Lassa virus associated with mammalian host adaptation.

Genomic changes of Lassa virus associated with mammalian host adaptation.

Journal: BMC genomics
Published: March 11, 2025

Cross-protectivity of henipavirus soluble glycoprotein in an in vivo model of Nipah virus disease.

Cross-protectivity of henipavirus soluble glycoprotein in an in vivo model of Nipah virus disease.

Journal: Frontiers in immunology
Published: October 25, 2024

Comparison of Chikungunya Virus-Induced Disease Progression and Pathogenesis in Type-I Interferon Receptor-Deficient Mice (A129) and Two Wild-Type (129Sv/Ev and C57BL/6) Mouse Strains.

Comparison of Chikungunya Virus-Induced Disease Progression and Pathogenesis in Type-I Interferon Receptor-Deficient Mice (A129) and Two Wild-Type (129Sv/Ev and C57BL/6) Mouse Strains.

Journal: Viruses
Published: July 23, 2024

Pathogenesis of Rift Valley Fever Virus in a BALB/c Mouse Model Is Affected by Virus Culture Conditions and Sex of the Animals.

Pathogenesis of Rift Valley Fever Virus in a BALB/c Mouse Model Is Affected by Virus Culture Conditions and Sex of the Animals.

Journal: Viruses
Published: November 06, 2023

Publisher Correction: Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab')2 fragments.

Publisher Correction: Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab')2 fragments.

Journal: Scientific reports
Published: September 18, 2023

Establishment of a Nipah Virus Disease Model in Hamsters, including a Comparison of Intranasal and Intraperitoneal Routes of Challenge.

Establishment of a Nipah Virus Disease Model in Hamsters, including a Comparison of Intranasal and Intraperitoneal Routes of Challenge.

Journal: Pathogens (Basel, Switzerland)
Published: June 26, 2023
Showing 1-12 of 33

Last Updated: 09/26/2026